SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-025571
Filing Date
2011-03-15
Accepted
2011-03-15 16:25:28
Documents
12
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f58240e10vk.htm 10-K 1845486
2 EX-10.45 f58240exv10w45.htm EX-10.45 22537
3 EX-10.46 f58240exv10w46.htm EX-10.46 14843
4 EX-10.47 f58240exv10w47.htm EX-10.47 6569
5 EX-21.1 f58240exv21w1.htm EX-21.1 4146
6 EX-23.1 f58240exv23w1.htm EX-23.1 1704
7 EX-31.1 f58240exv31w1.htm EX-31.1 8886
8 EX-31.2 f58240exv31w2.htm EX-31.2 8940
9 EX-32.1 f58240exv32w1.htm EX-32.1 6185
10 GRAPHIC f58240f5824001.gif GRAPHIC 20144
11 GRAPHIC f58240f5824002.gif GRAPHIC 13215
12 GRAPHIC f58240f5824003.gif GRAPHIC 12853
  Complete submission text file 0000950123-11-025571.txt   1984409
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51820 | Film No.: 11688834
SIC: 2834 Pharmaceutical Preparations